🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Cardiac allograft vasculopathy (CAV) is a process of both immune and non-im...
Status
Terminated
Location
Queen Elizabeth II Health Science Centre
Start Date
2013-10-13
Trial ID
NCT01927614
Treatments Being Tested
Lymphatic Anomalies (LA) is characterized by proliferation of lymphatic tis...
Status
Completed
Location
Children's Hospital of Philadelphia
Start Date
2016-04
Trial ID
NCT02744027
This phase II trial tests effects of nivolumab in combination with chemothe...
Status
Recruiting
Location
Children's Hospital of Alabama
Start Date
2024-06-25
Trial ID
NCT06064097
Treatments Being Tested
This phase I trial studies the side effects and best dose of lapatinib when...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering Cancer Center
Start Date
2013-09-27
Trial ID
NCT01947023
This phase I trial tests the safety, side effects, and best dose of genetic...
Status
Terminated
Location
Roswell Park Cancer Institute
Start Date
2024-11-26
Trial ID
NCT06343376
This phase II trial studies the side effects of acalabrutinib, obinutuzumab...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2024-12-02
Trial ID
NCT06054776
This phase I/II trial studies the side effects and best dose of oncolytic m...
Status
Active Not Recruiting
Location
Mayo Clinic in Rochester
Start Date
2014-04-25
Trial ID
NCT02068794
Treatments Being Tested
This phase II MyeloMATCH treatment trial compares the effect of adding vene...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07-17
Trial ID
NCT06954987
Treatments Being Tested
This phase I trial tests the safety, side effects and best dose of anti-CD1...
Status
Active Not Recruiting
Location
Ohio State University Comprehensive Cancer Center
Start Date
2026-01-14
Trial ID
NCT07166419
This phase I trial tests the safety, side effects, and best dose of anti-gl...
Status
Recruiting
Location
Ohio State University Comprehensive Cancer Center
Start Date
2025-05-21
Trial ID
NCT06964737